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RESULTS

INTRODUCTION
• Standard of care for resectable pancreatic cancer according to the National
Comprehensive Cancer Network (NCCN) guidelines includes surgery,
chemotherapy, and consideration of radiotherapy (1).
• Thomas Jefferson University Hospital (TJUH) is a high volume institution
with over 100 surgical pancreatic cancer cases per year.
• Adjuvant treatment at high volume centers is recommended at all stages (2,3),
and inpatients at TJUH routinely receive inpatient radiation and medical
oncology consultations prior to discharge to discuss the benefit of adjuvant
therapies (4).
• Despite these efforts and potential benefit to patients, the rate of follow up
and delivery of adjuvant therapies at TJUH have not be characterized.
• We retrospectively reviewed patients that received curative surgery at TJUH
to assess follow up, adjuvant treatment, and evaluated associated variables.
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Variables
n
Male
Female
Average age (years)
Median Distance from TJUH
(miles)
Median Household Income
(by zip code)

DISCUSSION
Values

Follow-Up Treatment
p-value
p-value

• Continuity of care at TJUH is low, with only 38% returning for follow up, and
34% receiving adjuvant therapy at our center.

61
33 (54%)
28 (46%)

0.631

0.979

68 (29 – 84)

0.661

0.337

42 (9 – 2,867)

0.651

0.495

$74,000
($26,000 - $200,000)

0.590

0.476

• Given that adjuvant chemotherapy at high volume centers is recommended in
all pancreatic cancer patients, this number is particularly concerning (2,3).
• There were no factors associated with follow up or treatment, most notably
distance from TJUH.
• Improved coordination may improve follow up, and emphasis of satellite
facility options may improve network capture.

Stage at Resection
0
IA
IB
IIA
IIB
III

1 (2%)
2 (3%)
9 (15%)
13 (21%)
27 (44%)
9 (15%)

Location of Disease
Head of Pancreas
Other

37 (61%)
24 (39%)

Total TJUH Follow Up
Medical Oncology
Radiation Oncology

23 (38%)
23 (38%)
10 (16%)

Total TJUH Adjuvant
Treatment
Medical Oncology
Radiation Oncology

21 (34%)

• Continuity of care of surgical pancreatic cancer patients treated at TJUH is
low, even among patients that live relatively near TJUH.

18 (30%)
3 (5%)

• Additional efforts to improve coordination of care to improve continuity are
warranted and may improve patient outcomes.

Neoadjuvant Treatment

0.088

0.821

• Limitations of our study include retrospective design, limited ability to
evaluate follow up at satellites, and lack of direct patient input.
• Future projects include evaluating follow up at satellites and affiliates,
evaluating impact of inpatient oncology consultations, and surveying patients.

0.073

0.535

CONCLUSION

8 (13%)
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• Logistic regression analysis was done to identify potential variables associated
with follow up and adjuvant treatment.
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